Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Algorae Pharmaceuticals.
RELATED STOCKHEAD STORIES
News
Closing Bell: It’s trickle down economics… just not the kind you’re thinking of
Health & Biotech
Check Up: As the pandemic winds down, what’s happening with Covid focused biotechs?
Health & Biotech
ASX Health Stocks: Oneview extends software deal, LCT to start using AI technology
News
Market Highlights and 5 ASX Small Caps to watch on Monday
Health & Biotech
Check Up: More clinical trials and FDA funding boost. Is this the end of biotech’s woes?
Health & Biotech
ASX Health Stocks: Clinical trials gather pace for Visioneering Tech, Anteris and other biotechs
Health & Biotech
Check up: 78 biotech companies rocked the boat this week but only one has real news
News
Reporting Season Round Up: Who shined on the ASX’s Judgement Day?
Health & Biotech
Check Up: Rhythm plans TGA submission and pig tissue MOU fails to impress
News
ASX Capital Raise Roundup: Low expectations + strong earnings =
Health & Biotech
ASX Health Stocks: Alterity moves to Phase 2 on cancer drug, Race Oncology secures 6th US patent
News
10 at 10: These ASX stocks have floated up high this morning
Health & Biotech
Cannabis, medtech, telehealth – could any of these health microcaps be the next multi-bagger?
Health & Biotech
These are the 22 small cap biotechs closest to bringing a drug to market
News
Weekly small cap wrap: Who received an award this week?
Health & Biotech
Check-up: Orthocell races ahead to lead the health and biotech pack
News
